Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Jinan Biomedical Research and Development Center is a high-tech biopharmaceutical enterprise specializing in the research, development, and industrialization of recombinant human growth factors. Affiliated with Jinan University, the center is a leader in protein engineering and regenerative medicine in China, focusing on therapeutic solutions for wound healing and tissue repair. Its core product portfolio includes recombinant human epidermal growth factor (rhEGF) and various fibroblast growth factors (rhbFGF, rhaFGF) used in clinical medicine and medical aesthetics. The center operates state-of-the-art GMP-compliant manufacturing facilities to produce high-purity biological raw materials and finished pharmaceutical products. By bridging academic research and commercial application, JNBIO has established itself as a key player in the global growth factor market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangzhou Jinan Biomedical Research and Development Center.